isoscopoletin has been researched along with hymecromone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, I; Hirono, S; Kato, A; Kobayashi, K; Minoshima, Y; Narukawa, K; Nash, RJ | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Ge, GB; Gonzalez, FJ; Li, SY; Liu, Y; Wang, JJ; Wang, P; Xia, YL | 1 |
3 other study(ies) available for isoscopoletin and hymecromone
| Article | Year |
|---|---|
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
Topics: Aldehyde Reductase; Animals; Binding Sites; Computer Simulation; Coumarins; Galactitol; L-Iditol 2-Dehydrogenase; Lens, Crystalline; Protein Structure, Tertiary; Rats; Rhodanine; Structure-Activity Relationship; Thiazolidines | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Synthesis and structure-activity relationship of coumarins as potent Mcl-1 inhibitors for cancer treatment.
Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Myeloid Cell Leukemia Sequence 1 Protein; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |